Literature DB >> 14961112

Evolutionary genetics: CCR5 mutation and plague protection.

Joan Mecsas1, Greg Franklin, William A Kuziel, Robert R Brubaker, Stanley Falkow, Donald E Mosier.   

Abstract

A recent and prevalent mutation in the chemokine receptor CCR5 in humans of northern European ancestry has been proposed to provide protection against bubonic plague. Here we infect both normal and CCR5-deficient mice with the bacterium Yersinia pestis, the cause of the plague epidemics that wiped out one-third of Europeans in the Middle Ages, and find no difference in either bacterial growth or survival time between the two groups. Unless the pathogenesis of Yersinia infection differs markedly between mice and humans, our results indicate that CCR5 deficiency in people is unlikely to protect against plague.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961112     DOI: 10.1038/427606a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation.

Authors:  S R Duncan; S Scott; C J Duncan
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

2.  Historic exposure to plague and present-day frequency of CCR5del32 in two isolated island communities of Dalmatia, Croatia.

Authors:  Mladen Smoljanović; Smiljana Ristić; Caroline Hayward
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

Review 3.  The attraction of chemokines as a target for specific anti-inflammatory therapy.

Authors:  James E Pease; Timothy J Williams
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 4.  Yersinia pestis: the Natural History of Plague.

Authors:  R Barbieri; M Signoli; D Chevé; C Costedoat; S Tzortzis; G Aboudharam; D Raoult; M Drancourt
Journal:  Clin Microbiol Rev       Date:  2020-12-09       Impact factor: 26.132

5.  Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice.

Authors:  Nathaniel D Lambert; Deanna M Langfitt; Matthew L Nilles; David S Bradley
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

6.  Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.

Authors:  Yasemin H K Congleton; Christine R Wulff; Edward J Kerschen; Susan C Straley
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

Review 7.  Evolutionary molecular medicine.

Authors:  Randolph M Nesse; Detlev Ganten; T Ryan Gregory; Gilbert S Omenn
Journal:  J Mol Med (Berl)       Date:  2012-04-29       Impact factor: 4.599

8.  Staphylococcus aureus and CCR5: unveiling commonalities in host-pathogen interactions and potential treatment strategies.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

9.  Historic, demographic, and genetic evidence for increased population frequencies of CCR5Delta32 mutation in Croatian Island isolates after lethal 15th century epidemics.

Authors:  Zrinka Biloglav; Lina Zgaga; Mladen Smoljanović; Caroline Hayward; Ozren Polasek; Ivana Kolcić; Veronique Vitart; Tatijana Zemunik; Vesna Boraska; Vesela Torlak; Rosanda Mulić; Darko Ropac; Ivica Grković; Diana Rudan; Smiljana Ristić; Maja Barbalić; Harry Campbell; Alan F Wright; Igor Rudan
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

10.  Study of the role of CCR5 in a mouse model of intranasal challenge with Yersinia pestis.

Authors:  Katie L Styer; Eva M Click; Gregory W Hopkins; Richard Frothingham; Alejandro Aballay
Journal:  Microbes Infect       Date:  2007-05-03       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.